Article Text

Download PDFPDF

PA-267 Altered mycobacterium tuberculosis (Mtb)-specific T-cell responses in comorbid tuberculosis and type 2 diabetes mellitus
Free
  1. Phillip Ssekamatte1,
  2. Sande James Obondo1,
  3. Reinout van Crevel2,
  4. Irene Andia Biraro1
  1. 1Makerere University, Uganda
  2. 2Radboud University Medical Centre, The Netherlands

Abstract

Background Tuberculosis (TB) is one of the leading causes of death from a single infectious agent with approximately 1.4 million deaths annually. Efforts to eradicate TB are threatened by diabetes mellitus (DM), which confers a greater than a 3-fold TB disease risk. Both TB and DM are accompanied by marked immunologic changes, however, changes in Mtb-specific T-cell functional responses remain poorly characterised. We compared Mtb-specific CD4+ and CD8+ T-cell functional responses among patients with LTBI-DM (21), DM (16), ATB (19) and ATB-DM (04).

Methods Peripheral blood mononuclear cells were stimulated with ESTA-6/CFP-10 peptide pools or PHA, and characterised Mtb-specific CD4+ and CD8+ T cell functional memory (CD45RA/CCR7), activation (HLA-DR), exhaustion (PD-1) and apoptosis (Bcl-2) profiles by flow cytometry. Data were analysed using FlowJo v.10.8.2 and Prism v.8.4.

Results Central memory CD4+/CD8+ T cells were decreased in ATB [median (IQR): 30.80 (20.70–34.80)] compared to DM [41.35(36.63–57.13)] (P<0.0001)/(P=0.0388) and LTBI-DM [45.60(38.75–50.40)] (P<0.0001)/(P=0.0028) patients. Effector memory CD8+ T cells were decreased in DM [21.50(15.18–30.28)] compared to LTBI-DM [32.00(23.45–43.80)] (P=0.0193) patients. TEMRA CD4+ phenotypes were decreased in ATB [1.17(0.88–2.83)] compared to LTBI-DM [0.70(0.30–1.26)] (P=0.0040) and DM [0.99(0.41–1.34)] (P=0.0057) patients. CD4+ T cell HLA-DR expression was upregulated in ATB [2.49(1.12–3.49)] compared to LTBI-DM [1.16(0.89–1.43)] (P=0.0016) and DM [1.63(0.99–2.33)] (P=0.0235) patients. CD4+/CD8+ T cell PD-1 expression was upregulated in LTBI-DM [1.77(1.49–2.94)] compared to DM [1.63(0.95–2.07)] (P=0.0499) and ATB-DM [0.62(0.33–0.94)] (P=0.0381) patients. Finally, CD4+ T cell Bcl-2 expression was increased in ATB [4.17(2.99–5.87)] compared to LTBI-DM [2.08(1.44–3.71)] (P=0.0077) patients.

Conclusion ATB decreases CD4+/CD8+ T-cell central memory while DM decreases CD8+ T-cell effector memory compromising immune surveillance and production of effector cytokines against TB. DM upregulates TEMRA, cells less protective against Mtb. CD4+/CD8+ T cells are exhausted possibly due to persistent inflammation and Mtb-exposure but remain anti-apoptotic. Loss of PD-1 mediated inhibition in DM could promote severe TB disease.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.